Li, Pengfei, Wang, Yining, Lavrijsen, Marla et al. SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination. // Cell Research. – 2022. – DOI: 10.1038/s41422-022-00618-w. – URL: https://www.nature.com/articles/s41422-022-00618-w
Li, Pengfei, Wang, Yining, Lavrijsen, Marla, Lamers, Mart M, Vries, Annemarie C, Rottier, Robbert J, Bruno, Marco J, Peppelenbosch, Maikel P, Haagmans, Bart L, Pan, & Qiuwei (2022). SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination. Cell Research. https://doi.org/10.1038/s41422-022-00618-w
Li, et al. “SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination.” Cell Research, 2022. doi:10.1038/s41422-022-00618-w.
@article{Li2022,
title = {SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination},
author = {Li and Pengfei and Wang and Yining and Lavrijsen and Marla and Lamers and M., Mart and Vries and C., Annemarie and Rottier and J., Robbert and Bruno and J., Marco and Peppelenbosch and P., Maikel and Haagmans and L., Bart and Pan and Qiuwei},
journal = {Cell Research},
year = {2022},
doi = {10.1038/s41422-022-00618-w},
url = {https://www.nature.com/articles/s41422-022-00618-w}
}